15-(s)-Hydroxyeicosatetraenoic acid (15-
) is the predominant oxidative metabolite of arachidonic acid in both normal and asthmatic airways.' Release of 15-HETE from asthmatic airways is greatly enhanced by allergen challenge in vitro and in vivo.' 2 When stimulated appropriately human eosinophils3 and airway epithelial cells4 5 release 15-HETE as their major lipid product and this may be the source of its release in allergic reactions affecting airway mucosal surfaces, as in asthma. Despite overwhelming evidence for the generation of 15-HETE in asthma, the role of this eicosanoid is still undefined. In vitro 1 5-HETE is able to stimulate leukotriene synthesis by mast cells67 and this action may be responsible for the potentiating effect of 15-HETE on allergen induced early asthmatic response8 as this is largely a mast cell mediated event. We may plausibly speculate that the reduced mucociliary clearance seen during the early asthmatic response9 may be initiated by the substantial amount of 15-HETE generated in the airways after allergen stimulation.' This reduction in mucociliary clearance is blocked by pretreatment with sodium cromoglycatet" or the leukotriene antagonist FPL-55712,9 suggesting that mediators released from mast cells, and in particular the leukotrienes, may have a role. Besides acting via the mast cell mediators, 15-HETE may also act directly to impair mucociliary clearance in asthma, as it has been shown to be a potent mucus secretagogue in canine airways in vivo and in human airways in vitro." 12 We therefore studied the effect of inhaled 1 5-HETE on mucociliary clearance in non-asthmatic subjects.
Methods

SUBJECTS
Ten healthy non-smokers with no history of asthma took part in the study (table 1) . They took no medication and had been free from respiratory tract infections for at least four weeks before the study. Five subjects were atopic as defined by positive skinprick tests (weal response of more than 2 mm) with two or more allergens-grass pollen, Dermatophagoides pteronyssinus, and cat dander (Bencard, Brentford, Middlesex). The study was approved by the Royal Free Hospital's ethical practices subcommittee, and written informed consent was obtained from each subject.
MEASUREMENTS
Forced expiratory volume in one second (FEVy) and forced vital capacity (FVC) were measured with a dry bellows spirometer (Vitalograph, Buckingham) 10 to 20 minutes before each radioaerosol inhalation. The highest value from three technically acceptable measurements was recorded. All readings were corrected for body temperature and ambient pressure. 
Results
Baseline pulmonary function, inspiratory flow rates, penetration indices, and alveolar depositions did not differ significantly on the two study days (table 2) .
Only one subject (No 6) had a productive cough after inhaling placebo and the tracheobronchial retention curve was corrected as described previously.'5 Tracheobronchial clearance after inhalation of 1 5-HETE was almost identical to that after placebo whether AUC was calculated for the first three hours (138 (8-6) v 135 (11-1) % h, NS) or for the whole six hours (173 (16-0) v 173 (19-0) % h, NS; Figure) .
Discussion
In this study inhaled 15-HETE had no measurable effect on tracheobronchial clearance in normal subjects. With the nebulisation procedure used, about 10% of the dose administered to the mouth-that is, 8 nmolshould have been delivered to the airways of our subjects. This is more than 10 times the dose administered to normal mongrel dogs by Johnson et al, who reported mucus hypersecretion and inflammatory changes in the airways of Table 2 Mean (SE) baseline spirometric values, inspiratoryflow rates, penetration indices, and alveolar deposition in the 10 subjects on the two study days* on canine and human airways probably reflect a species difference in the biological function of this mediator. Thus inhaled 15-HETE had no effect on tracheobronchial clearance in normal subjects. This result, with our earlier findings that 15-HETE reduces human airways responsiveness in both normal and asthmatic subjects'6 and has no effect on the allergen induced late asthmatic response,8 suggests that this mediator, though present in great quantity in the asthmatic airways, is unlikely to be directly responsible for the inflammatory changes seen in this disorder.
We thank Ms H Yeung for typing the manuscript. This work was supported by the National Asthma Campaign, UK. 
Inha6-
